Concept Life Sciences recently showcased its ability to rapidly transfer a client process into its own GMP facilities, enabling the manufacture of 1.5 kg of API to support early-phase clinical trials.
The China pharmaceutical intermediate market is set for significant expansion, with a projected valuation of USD 9,309.7 million in 2025, growing at a CAGR of 6.4% to reach USD 17,276.3 million by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback